|
By Gerard E.
Spinnler, Joseph P. Salanitro, Paul M. Maner and Karen A.
Lyons
Introduction
The removal
of MTBE dissolved in groundwater has turned out to be a
difficult task. Conventional remediation methods used
successfully for other petroleum constituents have proven
difficult, ineffective or financially prohibitive to remediate
MTBE. We have demonstrated an in-situ biological method that
degrades gasoline oxygenates to CO2 and water that overcomes
many of the hurdles encountered with conventional MTBE
remediation approaches.
There are
several strategies for in situ bioremediation of MTBE. The
most straightforward is natural or intrinsic bioremediation,
where MTBE biodegrades as a result of natural microbes present
in soil. So far, the evidence indicating intrinsic
bioremediation of MTBE is inconclusive. In fact, the extreme
length of some MTBE plumes implies intrinsic bioremediation
does not occur at rates capable of controlling plume
migration.
Biostimulation is the process of adding oxygen and/or
nutrients to stimulate natural MTBE degraders present (but
inactive) in the soil. We have successfully demonstrated
biostimulation at Port Hueneme Naval Base in California (see
Soil Sediment & Groundwater MTBE Special Issue-March 2000) by
adding oxygen to the aquifer. MTBE was present at low PPM
concentrations and biodegraded after a substantial lag period.
Other researchers have claimed similar success in low
concentration MTBE plumes using oxygen stimulation. Microcosm
experiments done in our laboratory from soil collected at MTBE
contaminated sites indicated MTBE-degrading microorganisms
were present at few sites. The presence of natural degraders
does not, by itself, insure biodegradation will be successful.
Degraders need to be present in sufficient quantities and
respond to stimulation.
Adding MTBE
degraders as well as O2 and/or nutrients to degrade MTBE in
the aquifer is termed bioaugumentation. We have demonstrated
MTBE and TBA degrading to CO2 and water by adding a mixed
culture of MTBE-degrading microorganisms and oxygen into the
aquifer at Port Hueneme as well as at retail gasoline stations
throughout the U.S.
This report
will detail MTBE bioremediation using bioaugmentation at two
retail gas stations.
TECHNOLOGY
OVERVIEW
A leak from a
UST resulted in an MTBE plume in groundwater. At the leading
edge of the plume, an oxygen gas injection well is supplying
oxygen to the local surrounding area. MTBE-degrading microbes
have been placed in the aquifer (indicated by the green
rectangle) and form a continuous “biobarrier” that the MTBE
plume will flow through. MTBE-contaminated water flowing
through the microbe and oxygen-rich zone will contact the
microbes and be degraded to CO2 and water.
MTBE-degrading
microbes are introduced to the subsurface through special
injection techniques or through infilling a trench. Oxygen is
supplied to the subsurface either by pulse injecting oxygen
gas or air. Unlike other systems, BioRemedy does not require
the addition of co-substrates such as other hydrocarbons to
degrade MTBE. All that is necessary in the BioRemedy process
is oxygen and proprietary MTBE-degrading microbes.
MTBE-degrading
culture
Microorganisms capable of degrading MTBE are not so ubiquitous
as BTEX degraders. As previously mentioned, few soils
collected from MTBE contaminated sites showed any MTBE-degrading
activity when stimulated with oxygen. We identified a
proprietary mixed culture (MC) capable of aerobically
degrading MTBE as well as the other common gasoline
oxygenates, including TBA. This mixed culture has been
sustained and is currently being grown in commercial
quantities for MTBE remediation purposes.
The soil
alone had no activity for degrading MTBE, even though it was
oxygenated. Soil with mixed culture showed various rates of
MTBE degradation depending on the amount of mixed culture
applied. Thus, using soil from a contaminated site we did not
observe natural MTBE degraders, however, MTBE did degrade in
soil amended with MC.
MTBE
Remediation at Retail Gas Stations
The enhanced
MTBE bioremediation process, BioRemedy, was applied at a
retail gas station in California. The site had a history of
MTBE concentrations greater than 20 mg/L. The tanks had been
excavated along with surrounding soil, yet MTBE concentrations
persisted downgradient of the former tanks and dispensers. A
biobarrier approach was implemented to reduce the MTBE
concentrations.
Eighteen
oxygen-injection well points were installed in a line along
the downgradient property boundary and perpendicular to the
flow direction. Existing subsurface information and pilot test
results determined the location and depth of the wells. The
oxygen points were installed at five-foot lateral spacings.
Mixed culture was injected at one-foot centers laterally and
vertically throughout the saturated zone (~3-10 ft. bgs) along
the same line as the oxygen points
MC was also
added to an existing groundwater-extraction trench located
about 10 feet upgradient of the biobarrier. Since the trench
already existed, we decided to add MC to enhance MTBE
degradation. The trench was retrofitted with an oxygen supply
system using the perforated drain pipe located in the base of
the trench. MC was injected using similar methodology as in
the biobarrier (Fig. 3a).
The oxygen
generation system consists of a commercial air compressor
connected to an oxygen generator. The output of the oxygen
generator fills a 120-gallon storage tank, and that in turn is
connected to various injection points through solenoids. The
sequencing of the unit is controlled electronically and has a
telemetry system capable of diagnosing and communicating its
operating conditions.
Rapid
reduction of high MTBE concentration was accomplished using
BioRemedy at this site.
Another
BioRemedy remediation system is located at a retail site in
Connecticut. This site had MTBE concentrations as high as 100
mg/. Pump and treat had been implemented at the site without
success. A biobarrier approach was chosen to curtail the
offsite migration of dissolved MTBE. Pilot test data indicated
the need for oxygen injection wells spaced approximately 5 ft.
laterally and at two depths. Monitoring wells were placed
upgradient and downgradient of the biobarrier to monitor
performance. MC was injected on two-foot centers both
laterally and vertically across the site using direct push
tools and specially designed injection tips and an injection
pump. The oxygen system was improved to maximize oxygen
distribution. Solenoids control the flow to individual wells.
The system is controlled by an electronic sequencer and has
telemetry. A fax is sent when an operational interruption
occurs and the status of the system can be determined remotely
via a modem connection.
Site
Selection and Installation Process
BioRemedy is
commercially available and may be an appropriate remediation
technology for MTBE and TBA at a variety of sites. The
process of implementing BioRemedy at a site starts with a
review of existing site assessment data. Suitable sites
generally are characterized by unconsolidated sediments, a
constant or near constant groundwater flow direction, water
level fluctuation less that 10 feet, and depth to groundwater
less than 25 feet bgs. Heterogeneous or low permeability
soils may require a biobarrier-type trench. A pilot test may
be performed to determine gas distribution. Additional
lithologic data and vertical delineation of the MTBE plume may
also be necessary.
Oxygen-injection wells are usually installed prior to the
microbe injection to allow for sufficient oxygenation of the
subsurface. Groundwater flow velocity and MTBE concentration
determine the needed amount of microbes. Microbes are shipped
to the site and injected, generally using direct push methods
and specialized injection equipment.
Summary
BioRemedy has
been successful at controlling the offsite migration of MTBE
plumes at retail gas stations. BioRemedy offers several
advantages over conventional MTBE remediation such as pump and
treat. BioRemedy is an in situ process, eliminating the need
for handling water above ground. No discharge permits or fees
are necessary. No air permits are required. Since it is an
in situ process, degradation occurs in the ground, and the
system has a very low surface profile and visual impact. The
contaminants are truly destroyed not just changed to another
phase.
BioRemedy is
commercially available. For more information check
www.bioremedy.com.
Gerard E.
Spinnler, Joseph P. Salanitro, Paul M. Maner and Karen A.
Lyons all work at Westhollow Technology Center in Houston TX.
BioRemedy is marketed by Shell Global Solutions (US) of
Houston, TX.
Top |